Alix Marduel Net Worth & Insider Trades
Alix Marduel Corcept Therapeutics Inc
What is Alix Marduel's Net Worth?
The current estimated net worth of Corcept Therapeutics Inc's Alix Marduel is estimated to be about $58.84M . Alix Marduel owns about 166,491 units of Corcept Therapeutics Inc common stock. In the last 4 years at Corcept Therapeutics Inc, Alix Marduel has sold an estimated value of $0 worth.
What is Alix Marduel's Past Insider Trading?
Alix Marduel's largest purchase order was 1,059,135 units , worth over $2.93M on March 26, 2008. In total, Alix Marduel has made about 7 transactions over 4 years of their time at Corcept Therapeutics Inc. Alix Marduel usually trades in August and April, with the busiest year in 2007.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALTA BIOPHARMA PARTNERS II LP, ALIX MARDUEL, JEAN DELEAGE, FARAH CHAMPSI, ALTA BIOPHARMA MANAGEMENT II LLC, ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC, ALTA PARTNERS II INC
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Alix Marduel's' Mailing Address?
- Mailing address is One Embarcadero Center Suite 3700 San Francisco CA 94111 CA
Corcept Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|
Joseph K. Belanoff, M.D., | 2020 | $769,567 | $744,000 | $4,237,643 | $10,892 | $5,762,102 |
Joseph K. Belanoff, M.D., | 2019 | $707,525 | $745,290 | $3,506,155 | - | $4,958,970 |
Joseph K. Belanoff, M.D., | 2018 | $679,792 | $477,750 | $5,157,075 | - | $6,314,617 |
Andreas Grauer, M.D., | 2020 | $454,550 | $219,157 | $1,271,293 | $118,274 | $2,063,274 |
Andreas Grauer, M.D., | 2019 | $362,267 | $243,720 | $3,115,335 | $78,245 | $3,799,567 |
Hazel Hunt, Ph.D., | 2020 | $431,873 | $243,000 | $2,084,640 | - | $2,759,513 |
Sean Maduck, | 2020 | $474,380 | $214,157 | $2,508,404 | - | $3,196,941 |
Sean Maduck, | 2019 | $456,133 | $308,881 | $1,476,276 | - | $2,241,290 |
Sean Maduck, | 2018 | $436,667 | $198,000 | $2,171,400 | - | $2,806,067 |
Charles Robb, | 2020 | $474,380 | $321,236 | $2,118,822 | - | $2,914,438 |
Charles Robb, | 2019 | $456,133 | $308,881 | $1,845,345 | - | $2,610,359 |
Charles Robb, | 2018 | $436,667 | $237,600 | $2,171,400 | - | $2,845,667 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1088856/000162828021007363/a2021def14a.htm
What are Corcept Therapeutics Inc's Past Insider Trades?
Corcept Therapeutics Inc's most recent insider trade came on December 6, 2023 by Gary Charles Robb who sold 16,381 units worth $434.84K . In the last 19 years, insiders at Corcept Therapeutics Inc have sold an estimated value of $206.96M and bought an estimated value of $188.83M worth of shares. Insider trading is most common in February, with the busiest year in 2006. The most active traders at the company are Joseph K Belanoff, Chief Executive Officer, Robert Roe, President and Secretary, and Leonard Baker Jr, Director .
CORCEPT THERAPEUTICS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |